参考文献/References:
[1] YASUDA E,NAKAMURA R,MATSUGI R,et al. Association between the severity of symptomatic knee osteoarthritis and cumulative metabolic factors[J]. Aging Clin Exp Res,2018,30(5):481-488.
[2] 齐张旸,张志明,郭燕芬,等.代谢综合征对双膝骨关节炎病情影响临床分析[J]. 中国医药科学,2016,6(4):139-141.
[3] DELL'ISOLA A,STEULTJENS M. Classification of patients with knee osteoarthritis in clinical phenotypes:Data from the osteoarthritis initiative[J]. PLoS One,2018,13(1):e191045.
[4] DELL'ISOLA A,ALLAN R,SMITH S L,et al. Identification of clinical phenotypes in knee osteoarthritis:a systematic review of the literature[J]. BMC Musculoskelet Disord,2016,17(1):425-430.
[5] GANDHI R,RAZAK F,TSO P,et al.Asian ethnicity and the prevalence of metabolic syndrome in the osteoarthritic total knee arthroplasty population[J].The Journal of Arthroplasty,2010,25(3):416-419.
[6] INOUE R,ISHIBASHI Y,TSUDA E,et al. Medical problems and risk factors of metabolic syndrome among radiographic knee osteoarthritis patients in the Japanese general population[J]. J Orthop Sci,2011,16(6):704-709.
[7] MARTIN K R,KUH D,HARRIS T B,et al. Body mass index,occupational activity,and leisure-time physical activity:an exploration of risk factors and modifiers for knee osteoarthritis in the 1946 British birth cohort[J]. BMC Musculoskelet Disord,2013,14:219-224.
[8] GUDBERGSEN H,BOESEN M,CHRISTENSEN R,et al. Changes in bone marrow lesions in response to weight-loss in obese knee osteoarthritis patients:a prospective cohort study[J]. BMC Musculoskelet Disord,2013,14:106-110.
[9] HANGAARD S,GUDBERGSEN H,SKOUGAARD M,et al. Point of no return for improvement of cartilage quality indicated by dGEMRIC before and after weight loss in patients with knee osteoarthritis:a cohort study[J]. Acta Radiol,2018,59(3):336-340.
[10] ZHOU M,CHEN J,WANG D,et al. Combined effects of reproductive and hormone factors and obesity on the prevalence of knee osteoarthritis and knee pain among middle-aged or older Chinese women:a cross-sectional study[J]. BMC Public Health,2018,18(1):1192-1196.
[11] KLUZEK S,ARDEN N K,NEWTON J. Adipokines as potential prognostic biomarkers in patients with acute knee injury[J]. Biomarkers,2015,20(8):519-525.
[12] KOHARA K,OCHI M,OKADA Y,et al.Clinical characteristics of high plasma adiponectin and high plasma leptin as risk factors for arterial stiffness and related end-organ damage[J].Atherosclerosis,2014,235(2):424-429.
[13] LUO Q,QIN X,QIU Y,et al. The change of synovial fluid proteome in rabbit surgery-induced model of knee osteoarthritis[J]. Am J Transl Res,2018,10(7):2087-2101.
[14] CUZDAN C N,AY S,EVCIK F D,et al. Adiponectin:is it a biomarker for assessing the disease severity in knee osteoarthritis patients?[J]. Int J Rheum Dis,2017,20(12):1942-1949.
[15] FRANCIN P J,ABOT A,GUILLAUME C,et al.Association between adiponectin and cartilage degradation in human osteoarthritis[J].Osteoarthritis and Cartilage,2014,22(3):519-526.
[16] KOSKINEN A,VUOLTEENAHO K J,MOILANEN T,et al.Resistin as a factor in osteoarthritis:synovial fluid resistin cocentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3[J].Scandinavian Journal of Rheumatology,2014,43(3):249-253.
[17] SCOTECE M,CONDE J,VOULTEENAHO K,et al.Adipokines as drug targets in joint and bone disease[J].Drug Discovery Today,2014,19(3):241-258.
[18] KLEIN-WIERINGA I R,KLOPPENBURG M,BASTIAANSEA-JENNISKENS Y M,et al.The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype[J].Annals of the Rheumatic Diseases,2011,70(5):851-857.
[19] ATUKORALA I,KWOH C K,GUERMAZI A,et al. Synovitis in knee osteoarthritis:a precursor of disease?[J].Ann Rheum Dis,2016,75(2):390-395.
[20] SCHETT G,KLEYER A,PERRICONE C,et al. Diabetes is an independent predictor for severe osteoarthritis:results from a longitudinal cohort study[J]. Diabetes Care,2013,36(2):403-409.
[21] DUBEY N K,NINGRUM D,DUBEY R,et al. Correlation between diabetes mellitus and knee osteoarthritis:a dry-to-wet lab approach[J]. Int J Mol Sci,2018,19(10):E3021.
[22] MARIELY N P,CASTRO-SANTANA L E,FONT Y M,et al.Association of hand or knee osteoarthritis with diabetesmellitus in a population of hispanics from puerto rico[J].Journal of Clinical Rheumatology,2013,19(1):1-6.
[23] ADEYEMI W J,OLAYAKI L A. Diabetes escalates knee osteoarthritis in rats:evidence of adaptive mechanism[J]. Environ Toxicol Pharmacol,2018,61:1-7.
[24] LEUNG Y Y,ALLEN J C,ANG L W,et al. Diabetes mellitus and the risk of total knee replacement among Chinese in singapore,the Singapore Chinese health study[J]. Sci Rep,2017,7:40671.
[25] KIDWAI S S,SIDDIQI S A,NAZIR L,et al. Relationship of anthropometric measures with knee osteoarthritis in diabetes mellitus[J]. Pak J Med Sci,2016,32(5):1077-1081.
[26] SO M W,LEE S,KIM S H. Association between dietary glycemic index and knee osteoarthritis:the korean national health and nutrition examination survey 2010-2012[J]. J Acad Nutr Diet,2018,118(9):1673-1686.
[27] FERNANDES G S,VALDES A M.Cardiovascular disease and osteoarthritis:common pathways and patient outcomes[J].Eur J Clin Invest,2015,45(4):405-414.
[28] VERONESE N,STUBBS B,SOLMI M,et al. Knee osteoarthritis and risk of hypertension:a longitudinal cohort study[J]. Rejuvenation Res,2018,21(1):15-21.
[29] 黄志,刘瀚霖,魏垒,等.原发性膝骨关节炎合并高血压的临床研究[J]. 实用骨科杂志,2017,23(4):319-322.
[30] SOWERS J R,WHITE W B,PITT B,et al.The effects of cyclooxygenase-2inhibitorsand nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension,osteoarthritis,and type 2diabetes mellitus[J].Arch Inter Med,2005,165(2):161-168.
[31] ILIC K,OBRADOVIC N,VUJASINOVIC-STUPAR N.The relationship among hypertension,antihypertensive medications,and osteoporosis:a narrative review[J].Calcif Tissue Int,2013,92(3):217-227.
[32] WUHL E. Hypertension in childhood obesity[J]. Acta Paediatr,2019,108(1):37-43.
[33] MIRANDA J O,CERQUEIRA R J,BARROS H,et al. Maternal diabetes mellitus as a risk factor for high blood pressure in late childhood[J]. Hypertension,2019,73(1):e1-e7.
[34] TATSUMI Y,MORIMOTO A,ASAYAMA K,et al. Risk of developing type 2 diabetes according to blood pressure levels and presence or absence of hypertensive treatment:the Saku study[J]. Hypertens Res,2019,42(1):105-113.
[35] ITTERMANN T,WERNER N,LIEB W,et al. Changes in fat mass and fat-free-mass are associated with incident hypertension in four population-based studies from Germany[J]. Int J Cardiol,2019,274:372-377.
[36] FU L,ZHANG M,HU Y Q,et al. Gene-gene interactions and associations of six hypertension related single nucleotide polymorphisms with obesity risk in a Chinese children population[J]. Gene,2018,679:320-327.
[37] KIM Y Y,SEO E,BAEK J,et al. Effects of the relative distribution of body mass index on the incidence of hypertension and diabetes mellitus,using the korean obesity index[J]. Metab Syndr Relat Disord,2019,17(2):108-114.
[38] GAMBINERI A,PELUSI C. Sex hormones,obesity and type 2 diabetes:is there a link?[J]. Endocr Connect,2019,8(1):1-9.
[39] YASUDA E,NAKAMURA R,MATSUGI R,et al. Association between the severityof symptomatic knee osteoarthritis and cumulative metabolic factors[J]. Aging Clin Exp Res,2018,30(5):481-488.
[40] 李维薇,杨燕,汪受传,等.细胞代谢组学研究进展[J].南京中医药大学学报,2017,12(12):12-16.
[41] KIM J R,KIM H N,SONG S W. Associations among inflammation,mental health,and quality of life in adults with metabolic syndrome[J]. Diabetol Metab Syndr,2018,10:66-70.
[42] YASUDA E,NAKAMURA R,MATSUGI R,et al. Association between the severit y of symptomatic knee osteoarthritis and cumulative metabolic factors[J].Aging Clin Exp Res,2018,30(5):481-488.
[43] LE CLANCHE S,BONNEFONT-ROUSSELOT D,SARI-ALI E,et al. Inter-relations between osteoarthritis and metabolic syndrome:a common link?[J]. Biochimie,2016,121:238-252.